SUN Stock Overview
Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Surgical Innovations Group plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.0065 |
52 Week High | UK£0.012 |
52 Week Low | UK£0.0037 |
Beta | 0.65 |
11 Month Change | 0% |
3 Month Change | 52.94% |
1 Year Change | -43.48% |
33 Year Change | -72.34% |
5 Year Change | -68.29% |
Change since IPO | -99.60% |
Recent News & Updates
Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth
Jul 11Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues
Apr 19Recent updates
Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth
Jul 11Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues
Apr 19Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%
Dec 29Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture
Sep 07Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively
May 26Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?
Jun 15Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?
Sep 24Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?
Mar 29Shareholder Returns
SUN | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | -2.2% | -0.5% |
1Y | -43.5% | 6.5% | 7.9% |
Return vs Industry: SUN underperformed the UK Medical Equipment industry which returned 6.5% over the past year.
Return vs Market: SUN underperformed the UK Market which returned 7.9% over the past year.
Price Volatility
SUN volatility | |
---|---|
SUN Average Weekly Movement | 15.1% |
Medical Equipment Industry Average Movement | 5.9% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 9.3% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: SUN's share price has been volatile over the past 3 months.
Volatility Over Time: SUN's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 101 | David Marsh | www.sigroupplc.com |
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite port access systems; YelloPort +plus Resposable port access systems; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures.
Surgical Innovations Group plc Fundamentals Summary
SUN fundamental statistics | |
---|---|
Market cap | UK£6.06m |
Earnings (TTM) | -UK£509.00k |
Revenue (TTM) | UK£12.01m |
0.5x
P/S Ratio-11.9x
P/E RatioIs SUN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SUN income statement (TTM) | |
---|---|
Revenue | UK£12.01m |
Cost of Revenue | UK£8.57m |
Gross Profit | UK£3.45m |
Other Expenses | UK£3.96m |
Earnings | -UK£509.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 30, 2024
Earnings per share (EPS) | -0.00055 |
Gross Margin | 28.70% |
Net Profit Margin | -4.24% |
Debt/Equity Ratio | 8.1% |
How did SUN perform over the long term?
See historical performance and comparison